Utah State University

DigitalCommons@USU
Fall Student Research Symposium 2020

Fall Student Research Symposium

12-10-2020

Cloning Type IV-B CRISPR System into a Plasmid
Olivia Gornichec
Utah State University, oliviagornichec23@gmail.com

Kailey Welch
Utah State University, kailey.welch@aggiemail.usu.edu

Follow this and additional works at: https://digitalcommons.usu.edu/fsrs2020
Part of the Chemistry Commons

Recommended Citation
Gornichec, Olivia and Welch, Kailey, "Cloning Type IV-B CRISPR System into a Plasmid" (2020). Fall
Student Research Symposium 2020. 22.
https://digitalcommons.usu.edu/fsrs2020/22

This Book is brought to you for free and open access by
the Fall Student Research Symposium at
DigitalCommons@USU. It has been accepted for
inclusion in Fall Student Research Symposium 2020 by
an authorized administrator of DigitalCommons@USU.
For more information, please contact
digitalcommons@usu.edu.

Cloning Type IV-B CRISPR System Into a Target Plasmid
Kailey Welch, Olivia Gornichec, Dylan Keiser, Ryan Jackson
CRISPR Systems As Adaptive Immune
Systems in Microorganisms

Type IV-B as an Anti-CRISPR

Methods
To transplant the Type IV-B system into the
target plasmid we performed restriction enzyme
cloning, as shown in Figure 3. The success of
our project is dependent on the sequencing
results.
PCR Cleavage & Amplification of Type IV–B System

Double Digest of Target Plasmid

Figure 1: CRISPR Immunity

• Viruses outnumber the bacteria they infect 10 to 1
• Bacteria have evolved highly specialized immune
systems known as CRISPR-Cas systems.
• These diverse systems encode as memories (spacers)
copies of the nucleic acids which previously infected
the cell.
• The transcription of the CRISPR locus creates a
complementary RNA (crRNA) which can bind to new
invaders, marking them for termination by Cas
proteins.

Ligation & Amplification of Open Plasmid & Type IV–B

Colony PCR & Sequencing
Figure 3: Restriction Enzyme Cloning

without ACR (Anti-CRISPR) gene

Future Directions

Type IV--B System
• Type IV systems are newly discovered and have only
recently been categorized as Class I systems (using multi
subunits to bind crRNA)
• There are two types of Type IV systems
• Type IV - B systems are especially unique because they do
not encode the CRISPR locus that characteristically is
found on any system. Instead it encodes only the Cas
proteins.
• Characterizing the Type IV-B system could lead to
understanding it’s function and role in the cell.

Figure 5: Vector (Target Plasmid)
Digest (30 April 2020)

Figure 4: PCR Amplification of Type
IV-B System (18 February 2020)

Results
Type IV-A
• A successful colony PCR showed the E. coli which had taken up the transformed plasmid
and so those colonies were chosen for sequencing
• Sequencing results (Figure 6) show the cloning was successful. The top line is the Type IVB template with the several sequencing reactions below. Black color indicates the sequence
matches the template. Red zones show sequences that didn’t match. However, all red
zones overlap with black zones and so we know the entire system was cloned successfully.

Type IV-B

• Our hypothesis is that the Type IV-B system will act as an
anti-CRISPR, a system that will act to block the function of
another CRISPR function, to allow the bacteria to “choose”
if an invasive plasmid should be degraded or kept..
• A plasmid curing assay
will be performed using
our cloned plasmid to
determine if this is the
case.
• The bacteria grown with
the transformed Type
IV-B sequence on the
plasmid is predicted to
have growth because
the Type IV-B will block
the Type IV-A from
destroying the plasmid
and therefore retaining
the antibiotic resistance
gene and allow colonies
Figure 7: Plasmid Curing Assay with and
to grow.

Figure 2: Type IV CRISPR Systems

Figure 6: Sequencing results for Type IV-B in target plasmid

• The above-described plasmid curing assay is underway and we
hope to see results from that, shortly.
• However, if we do not
see the activity we are
expecting to see, this
could indicate that
ancillary proteins
integral to the Type IVB system.
• Ancillary proteins
found close to the
system in native
plasmids may be
integral to its function.
We can test this by
cloning the ancillary
proteins onto our new
plasmid
• This has been our
current project for the
past couple of months.
Figure 8: Cloning process for ancillary
proteins
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